Motley Fool Australia

This ASX small cap is predicting revenue growth of 20% this year, time to buy shares?

National Vet Care share price
Credit: Michael Gil

National Veterinary Care Ltd (ASX: NVL) is holding its AGM today and gave a trading update & guidance as part of the event.

In the presentation National Vet Care management reminded investors that in FY19 the company grew revenue by 43.6%, increased underlying earnings before interest, tax, depreciation and amortisation (EBITDA) by 37.7% and net profit rose by 28.9%. It also declared a dividend of 3.5 cents per share, an increase of 16.7%.

So far in FY20, National Vet Care has grown its network by 5.1% to 103 clinics, it has also increased its ‘best for pet’ members by 9.2% to 27,520. It has also increased the number of clinics using its management services (MS) by 17.4% to 500 – it now represents almost a quarter of the small animal market through its owned clinics and the ones using MS. It’s targeting 600 clinics by the end of FY20.

Excluding Pet Doctors, the group’s EBITDA margin improved from 16.2% in FY18 to 17.2% in FY19.

The vet business outlined a number of initiatives it plans to do to increase Pet Doctor’s EBITDA margin from 14.3% in 2018 to around 20% by the end of 2020, which will then be a similar level to the company’s other New Zealand clinics.

To improve group profitability further the company is focusing on using reporting tools to improve performance and help poorer performing clinics. It’s also merging some of the small clinics to benefit from larger size operations.

In September 2019 it opened its first greenfield clinic in Queensland with all the usual pet services including grooming, cat boarding and dog daycare. Radiation treatment and hydro therapy are planned. This is a larger-than-usual clinic to accommodate the dog daycare and a coffee shop.

Trading update and guidance

Over the 12 months to 30 September 2019, the company has achieved total organic growth of 2.46%.

It’s guiding FY20 underlying revenue to be above $140 million, which would be 20% growth above FY19’s revenue total. The underlying EBITDA margin is expected to be 15.5% to 16% in FY20, compared to a margin of 15.4% in FY19.

Foolish takeaway

So it seems National Vet Care is predicting revenue growth of at least 20% and that underlying EBITDA can grow even faster.

Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

*Returns as of 6/8/2020

Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of NATVETCARE FPO. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Related Articles...

Latest posts by Tristan Harrison (see all)